XML 67 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Benefit plans and stock-based compensation (Tables)
12 Months Ended
Mar. 30, 2024
Summary of Status of Stock Options
A summary of the status of Birks’ stock options at March 30, 2024 is presented below:

 
  
Options outstanding
 
  
Options exercisable
 
Exercise price
  
Number
outstanding
 
  
Weighted
average
remaining
life
(years)
 
  
Weighted
average
exercise
price
 
  
Number
exercisable
 
  
Weighted
average
exercise
price
 
$0.78
     20,000        1.5      $ 0.78        20,000      $ 0.78  
$1.43
     12,000        2.6        1.43        12,000        1.43  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     32,000        1.9      $ 1.02        32,000      $ 1.02  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Birks' Restricted Stock Units And Deferred Share Units
A summary of the status of the Company’s cash-settled RSUs and cash
-
settled DSUs at March 30, 2024 is presented below:
 
    
DSU
 
Outstanding March 27, 2021
     689,012  
Grants of new units
     61,470  
Converted to equity-settled awards
     (750,482
 
 
 
 
 
Outstanding March 26, 2022
     —   
Grants of new units
     35,584  
 
 
 
 
 
Outstanding March 25, 2023
     35,584  
Grants of new units
     70,000  
Exercised
     (8,896
 
 
 
 
 
Outstanding March 30, 2024
     96,688  
 
 
 
 
The fair value of cash
-
settled DSUs is measured based on the Company’s share price at each period end. As at March 30, 2024, the liability for all cash
-
settled DSU’s was $0.4 million (March 25, 2023 – $0.4 million
and
March 26, 2022 – nil). The closing stock price used to determine the liability for fiscal 2024 was $3.34
 ($8.18 as at March 26, 2023).
Total compensation cost (gain) for DSUs recognized in expense was ($0.3) million, $0.4 million, and $1.5 million in fiscal 2024, 2023, and 2022
, respectively
.
 
    
RSU
 
Outstanding March 27, 2021
     375,000  
Converted to equity-settled awards
     (325,000
 
 
 
 
 
Outstanding March 26, 2022
     50,000  
Exercised
     —   
 
 
 
 
 
Outstanding March 25, 2023
     50,000  
Exercised
     (50,000
 
 
 
 
 
Outstanding March 30, 2024
     —   
 
 
 
 
 
The fair value of cash
-
settled RSUs is measured based on the Company’s share price at each period end. As at March 30, 2024, the liability for all vested cash
-
settled RSUs was nil (March 25, 2023 - $0.5 million 
and
March 26, 2022 - $0.2 million). The closing stock price used to determine the liability was $8.18 for fiscal 2023 and $5.12 for fiscal 2022. Total compensation cost (gain) for cash-settled RSU’s recognized in expense was $(0.2) million, $0.3 million, and $0.8 million in fiscal 2024, 2023, and 2022
, respectively.
 Total compensation cost for equity-settled RSU’s recognized in expense was $0.03 million, $0.5 million, and $0.2 million in fiscal 2024, 2023, and 2022
, respectively
.
A summary of the status of the Company’s equity-settled
DSUs
at March 30, 2024 is presented below:
 
    
DSU
 
Outstanding March 25, 2023 and March 26, 2022
     750,482  
Exercised
     (10,000
 
 
 
 
 
Outstanding March 30, 2024
     740,482  
A summary of the status of the Company’s equity-settled
RSUs
at March 30, 2024 is presented below:
 
    
RSU
 
Outstanding March 26, 2022 and March 25, 2023
     325,000  
Exercised
     (325,000
 
 
 
 
 
Outstanding March 30, 2024
     —   
The equity
-
settled RSUs and DSUs are recorded at fair value at grant or modification date and not subsequently
re-measured.
Birks Stock Option Plan [Member]  
Summary of Activity of Stock Option Plans and Arrangements
The following is a summary of the activity of Birks’ stock option plans and arrangements.
 
    
Options
    
Weighted average
exercise price
 
Outstanding March 27, 2021
     395,147      $ 1.13  
Exercised
     (138,147      0.94  
Forfeited
     —         —   
  
 
 
    
 
 
 
Outstanding March 26, 2022
     257,000        1.09  
Exercised
     (225,000      1.10  
Forfeited
     —         —   
  
 
 
    
 
 
 
Outstanding March 25, 2023
     32,000        1.02  
Exercised
     —         —   
Forfeited
     —         —   
  
 
 
    
 
 
 
Outstanding March 30, 2024
     32,000      $ 1.02